QA: Anaptysbio INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001370053_2019_Anaptysbio_INC.pdf

Logs

Graph

Absolute values for 0001370053, Anaptysbio INC

  xvar xval
0 AssetsCurrent 434,216,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,445,000
3 remainder_Assets 73,336,000
4 LiabilitiesCurrent 21,836,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,526,000
9 ResearchAndDevelopmentExpense 56,196,000
10 remainder_Expenses -192,000
11 remainder_Revenues 5,000,000
12 remainder_NetIncome 4,874,000
13 remainder_ComprehensiveNetIncome 203,000
  yvar yval
0 Assets 508,997,000
1 Liabilities 21,836,000
2 Expenses 71,530,000
3 Revenues 5,000,000
4 StockholdersEquity 487,161,000
5 NetIncome -61,656,000
6 ComprehensiveNetIncome -61,554,500
7 BaseVar 306,220,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.77
9 EconomicCapitalRatio 4.22

Edgar->Model Mapping

Feature Distribution

Change over Time